group leader to the Institute of Cancer Research in London in 1981 by then Director, Robin Weiss. There, he started working with Chris Marshall on a long and productive collaboration. Together, they discovered and cloned the third Ras oncogene, N-Ras. They published a series of highly influential papers characterizing the biochemical properties and cellular functions of N-Ras.
In the late 1980s, Alan turned his attention to the Rho cDNAs that Chris had obtained but were sitting untouched in a freezer. Alan combined his chemistry, biochemistry, molecular biology, and newly developed cell biology skills to study Rho family proteins. He published his first paper on Rho, showing that Rho induced cell shape changes, in 1990. This opened up a whole new field of research. When I arrived in his laboratory in 1990, this was a field ripe for growth. It was a really exciting time at the Institute of Cancer Research. Chris Marshall's laboratory was identifying kinases downstream of Ras. Alan purified and characterized the first RhoGAP and realized that it had homology to a region of Bcr, which is fused to Abl in leukemias. This led to the identification of a huge family of Rho GAPs. We worked together to demonstrate that Rho and Rac were essential for extracellular signals to induce changes to the actin cytoskeleton and to coordinate cell migration.
In 1993, Alan moved to the newly formed MRC Laboratory of Molecular Cell Biology (LMCB) at University College London, which was started up by Colin Hopkins. He took over as head of the LMCB in 2001. Having convinced the MRC to give a lot more money to the LMCB, he hired excellent young group leaders, increased the PhD program size, and bought a top-class coffee machine. He created a strong and successful institute and balanced this admirably with a highly productive laboratory. At the LMCB, he recruited and worked with a series of excellent postdocs. For example, he worked with Kate Nobes to determine the function of Cdc42 in inducing filopodia, with Emmanuelle Caron to describe the roles of Rho GTPases in different types of phagocytosis, and with Sandrine Etienne-Manneville to show how Cdc42 and the Par polarity complex regulated polarized cell migration. Alan also wrote a series of influential and insightful reviews on Rho GTPase signaling with members of his laboratory.
Alan's talents were spotted by Memorial Sloan-Kettering Cancer Center in New York, and the London community sadly bid him farewell in 2006, when he moved to Sloan-Kettering as Chair of the Cell Biology Program. He expanded the cell biology program by recruiting several excellent new team leaders, leaving a strong program behind him. Alan's research in New York focused on roles of Rho GTPase signaling in epithelial polarity and collective cell migration. In a recent paper, he moved for the first time into in vivo studies on collective cell migration. This promised to be the start of a new area of research for him.
I first met Alan when I gave a short talk as a PhD student, working on Ras, at a meeting in the UK. Alan was chairing the session, and he asked me questions at the end that showed genuine interest in my results, not just because he was the session chair. This epitomized his character as a scientist-Alan touched so many scientists' lives by listening to them and taking a real interest in their results. At conferences, Alan went to posters and talks, asked insightful and constructive questions, and gave helpful advice. Alan was always generous with his time and with reagents, which he shared freely.
As a group leader, Alan was an inspirational mentor. He treated everyone in the laboratory equally and gave his postdocs the freedom to work on the projects they wanted to-they brought in their own model systems or chose their project based on previous results from the laboratory. Whatever the project, Alan supported us to achieve our best. He valued our ideas and input into the projects. This created a great atmosphere in the lab, where everyone helped each other, because nobody was in competition. He has left a big lab family, many of whom have gone on to be successful group leaders. We have all been influenced by his style of leadership: he was interested in everybody and went through our results carefully and thoroughly, discussing future experiments in a way that made sure we felt we owned them.
Alan The last time that I saw Alan was at a cell biology conference in Brazil, at which he was in fine form. We discussed everything from Rho mutations in gastric cancers to our children's career moves. Alan's sudden and tragic death has taken away an influential, generous, and kind leader in the field of cell signaling and GTPases. He leaves behind his wife Eileen, his daughter and son, and two grandchildren.
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